Newsroom | 23038 results

SAN DIEGO--(BUSINESS WIRE)--FairJourney Bio (FJBio), a global antibody discovery contract research organization (CRO), today announced the opening of its advanced cryo-electron microscopy (cryo-EM) structural biology facility in San Diego, California. The new site significantly expands the Company’s presence in the US market and incorporates atomic-resolution structural biology directly into its antibody discovery platform. The facility houses a state-of-the-art 300 kV cryo-EM infrastructure, i...

DURHAM, N.C.--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today released “Still Here,” a social media video campaign designed to spark crucial conversations about HIV among young people. This launch coincides with National Youth HIV/AIDS Awareness Day and aims to confront the alarming reality that HIV remains a significant and often overlooked public health issue, especially among young people. While great progress h...

LOS ANGELES--(BUSINESS WIRE)--New Billboards Tout AHF as Top HIV Provider, Promote STD Testing...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a developer of the leading AI foundation model for tumor and immune biology, today announced that 13 abstracts have been selected for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026, held from April 17 - 22, at the San Diego Convention Center in San Diego, CA. BostonGene will be exhibiting at booth #4613. BostonGene will demonstrate how its leading AI foundation model for tumor and immune biology is redefining...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has been ranked No. 1 in the Black Book Research survey of AI Clinical Decision Support solutions for the second consecutive year. Based on direct feedback from 1,237 healthcare professionals, including clinicians, administrators, and operational leaders across hospitals, health systems, and medical groups, the annual Black Book survey evaluates vendors on ent...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a part of Fresenius, and a leading provider of essential medicines and medical technologies, announced today that the Centers for Medicare & Medicaid Services has issued indication-specific Healthcare Common Procedure Coding System (HCPCS) codes for Tyenne® (tocilizumab-aazg) for the treatment of COVID-19. The new codes will be effective for Medicare claims for eligible patients administered Tyenne on April 1, 2026. These new COVID-19 HCPC...

OTTAWA, Ontario--(BUSINESS WIRE)--Virica Biotech (« Virica »), entreprise spécialisée dans les activateurs cellulaires et plus particulièrement les sensibilisateurs viraux (VSE™) pour la production de vecteurs viraux, a annoncé aujourd'hui qu'elle bénéficie de services de conseil et d'un financement du Programme d'aide à la recherche industrielle du Conseil national de recherches du Canada (PARI CNRC), dans le cadre du Programme de coinnovation Canada-Japon, lui permettant de collaborer avec FU...

OTTAWA, Ontario--(BUSINESS WIRE)--Virica Biotech („Virica“), ein auf Zellverstärker spezialisiertes Unternehmen, das Viral Sensitizers (VSE™) für die Herstellung viraler Vektoren entwickelt, gab heute bekannt, dass es im Rahmen des Canada–Japan Corporate Co-Innovation Program für eine Zusammenarbeit mit FUJIFILM Biosciences Beratungsleistungen und Finanzmittel vom Industrial Research Assistance Program (NRC IRAP) des National Research Council of Canada erhält. Die Zusammenarbeit konzentriert si...

OTTAWA, Ontario--(BUSINESS WIRE)--Virica Biotech ("Virica"), een bedrijf dat zich specialiseert in virale sensibilisatoren (VSE™) voor de productie van virale vectoren, heeft vandaag aangekondigd dat het adviesdiensten en financiering ontvangt van het Industrial Research Assistance Program (NRC IRAP) van de National Research Council of Canada. Dit vindt plaats in het kader van het Canada–Japan Corporate Co-Innovation Program voor een samenwerking met FUJIFILM Biosciences. Deze bekendmaking is o...

OTTAWA, Ontario--(BUSINESS WIRE)--Virica Biotech («Virica»), una empresa dedicada al desarrollo de potenciadores celulares especializada en sensibilizadores virales (VSE™) para la fabricación de vectores virales, ha anunciado hoy que recibirá servicios de asesoramiento y financiación del National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), en el marco del Canada-Japan Corporate Co-Innovation Program, para una colaboración con FUJIFILM Biosciences. El comunicado...